Insider Selling: Hinge Health (NYSE:HNGE) President Sells $860,640.00 in Stock

Hinge Health Inc. (NYSE:HNGE) President James Pursley sold 16,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $53.79, for a total transaction of $860,640.00. Following the completion of the transaction, the president owned 780,223 shares of the company’s stock, valued at $41,968,195.17. This trade represents a 2.01% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

James Pursley also recently made the following trade(s):

• On Monday, March 23rd, James Pursley sold 15,000 shares of Hinge Health stock. The stock was sold at an average price of $42.26, for a total transaction of $633,900.00.

Hinge Health Stock Performance

Shares of NYSE:HNGE opened at $56.13 on Friday. Hinge Health Inc. has a 52-week low of $30.08 and a 52-week high of $62.18. The firm has a fifty day moving average of $46.06 and a 200 day moving average of $44.67. The firm has a market capitalization of $4.34 billion and a PE ratio of -4.55.

Hinge Health (NYSE:HNGE) last announced its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The company had revenue of $182.31 million during the quarter. During the same quarter last year, the firm posted $1.30 earnings per share. The firm’s revenue was up 47.2% on a year-over-year basis. On average, sell-side analysts forecast that Hinge Health Inc. will post 1.21 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

HNGE has been the subject of several analyst reports. KeyCorp set a $55.00 price target on shares of Hinge Health in a research report on Wednesday, February 11th. Royal Bank Of Canada upped their price target on shares of Hinge Health from $55.00 to $65.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Citigroup restated an “outperform” rating on shares of Hinge Health in a research report on Wednesday, May 6th. Needham & Company LLC upped their price target on shares of Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Finally, Weiss Ratings upgraded shares of Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Hinge Health currently has a consensus rating of “Moderate Buy” and an average price target of $67.40.

Hedge Funds Weigh In On Hinge Health

Several hedge funds and other institutional investors have recently modified their holdings of HNGE. California State Teachers Retirement System boosted its holdings in shares of Hinge Health by 35.2% during the first quarter. California State Teachers Retirement System now owns 19,141 shares of the company’s stock worth $738,000 after purchasing an additional 4,986 shares during the period. Estuary Capital Management LP purchased a new stake in shares of Hinge Health during the first quarter worth about $15,201,000. Lazard Asset Management LLC boosted its holdings in shares of Hinge Health by 0.6% during the first quarter. Lazard Asset Management LLC now owns 63,705 shares of the company’s stock worth $2,456,000 after purchasing an additional 386 shares during the period. Entropy Technologies LP boosted its holdings in shares of Hinge Health by 28.1% during the first quarter. Entropy Technologies LP now owns 11,749 shares of the company’s stock worth $453,000 after purchasing an additional 2,579 shares during the period. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Hinge Health by 225.7% during the first quarter. Arrowstreet Capital Limited Partnership now owns 1,163,187 shares of the company’s stock worth $44,852,000 after purchasing an additional 806,007 shares during the period.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.